Predictors of Persistence in Patients With Schizophrenia Treated With Once-monthly Aripiprazole in Spain

CompletedOBSERVATIONAL
Enrollment

119

Participants

Timeline

Start Date

July 18, 2017

Primary Completion Date

July 30, 2018

Study Completion Date

July 30, 2018

Conditions
Schizophrenia
Trial Locations (15)

Unknown

Hospital Universitario de Álava, Alava

Hospital Fundación Alcorcón, Alcorcón

Numància Salut Mental (Parc Sanitari St Joan de Deu), Barcelona

Hospital de Ciudad Real, Ciudad Real

Hospital IAS Girona, Girona

Hospital Universitari Bellvitge, L'Hospitalet de Llobregat

Complejo Asistencial Universitario de Leon, León

Fundación Jiménez Díaz, Madrid

HGU Gregorio Marañón, Madrid

Hospital Infanta Leonor, Madrid

Hospital Carlos Haya, Málaga

Parc Sanitari St. Joan de Deu (St. Boi), Sant Boi de Llobregat

Hospital Santiago de Compostela, Santiago de Compostela

Hospital Universitario Virgen del Rocío, Seville

Hospital Álvaro Cunqueiro, Vigo

All Listed Sponsors
lead

Otsuka Pharmaceutical Europe Ltd

INDUSTRY

NCT03130478 - Predictors of Persistence in Patients With Schizophrenia Treated With Once-monthly Aripiprazole in Spain | Biotech Hunter | Biotech Hunter